At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Carbamazepine +1 moredrug
Likely dose
Carbamazepine 800 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression: A 42-Day, Single-Site, Forced-Titration, Parallel Group, Randomized, Double-Blind, Placebo Controlled Trial
In Brief
A clinical study evaluating Carbamazepine and Placebo for Traumatic Brain Injury. Completed, enrolled 70 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if carbamazepine reduces irritability and aggression among individuals with traumatic brain injury
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTraumatic Brain Injury
CountriesUnited States
CollaboratorsU.S. Department of Education
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedFeb 2008
Primary CompletionSep 2013
Study CompletionOct 2013
TodayJul 2026
First PostedFeb 22, 2008
Enrollment StartFeb 1, 2008
Primary CompletionSep 1, 2013
Study CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 18.4 years ago
Interventions
Carbamazepinedrug
800 mg daily
Placebodrug
Placebo